دورية أكاديمية

Monogenic obesity; using drugs to bypass the problem

التفاصيل البيبلوغرافية
العنوان: Monogenic obesity; using drugs to bypass the problem
المؤلفون: Coll, anthony
بيانات النشر: Elsevier
//dx.doi.org/10.1016/j.cmet.2018.06.015
Cell Metabolism
سنة النشر: 2018
المجموعة: Apollo - University of Cambridge Repository
مصطلحات موضوعية: Body Weight, Glucagon-Like Peptide-1 Receptor, Humans, Mutation, Obesity, Receptor, Melanocortin, Type 4
الوصف: Safe and effective pharmacological treatments for severe obesity remain scarce. In this issue, Iepsen et al. show that obese patients with pathogenic melanocortin 4 receptor mutations, the most common form of monogenic obesity, lose weight with glucagon-like peptide 1 (GLP-1) receptor agonist therapy. ; A.P.C. is supported by the Medical Research Council (MRC Metabolic Diseases Unit [MRC_MC_UU_12012/1]).
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: https://www.repository.cam.ac.uk/handle/1810/283544Test
DOI: 10.17863/CAM.30907
الإتاحة: https://doi.org/10.17863/CAM.30907Test
https://www.repository.cam.ac.uk/handle/1810/283544Test
حقوق: Attribution-NonCommercial-NoDerivatives 4.0 International
رقم الانضمام: edsbas.576A4D15
قاعدة البيانات: BASE